PALISADE CAPITAL MANAGEMENT, LP - TRINITY BIOTECH INVT LTD ownership

Back to all holdings Add to watchlist

TRINITY BIOTECH INVT LTD's ticker is and the CUSIP is 89643QAB4. A total of 5 filers reported holding TRINITY BIOTECH INVT LTD in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.8%.

Links
Filings
Quarter-by-quarter ownership
PALISADE CAPITAL MANAGEMENT, LP ownership history of TRINITY BIOTECH INVT LTD
ValueSharesWeighting
Q1 2017$699,000
-3.2%
850,0000.0%0.03%0.0%
Q4 2016$722,000
-10.8%
850,0000.0%0.03%
-6.9%
Q3 2016$809,000
+0.4%
850,000
-4.8%
0.03%0.0%
Q2 2016$806,000–893,000–0.03%–
 Download
Other shareholders
TRINITY BIOTECH INVT LTD shareholders Q2 2017
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of TRINITY BIOTECH INVT LTD shareholders